72 results
DEFA14A
AUPH
Aurinia Pharmaceuticals Inc
4 Jun 24
Additional proxy soliciting materials
5:25pm
on a Board that would oversee such a strategy. Seasoned Board with New Directors and Deep Industry and Leadership Experience – Supported by a Leading
8-K
EX-99.1
AUPH
Aurinia Pharmaceuticals Inc
5 Jan 24
Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-year 2023 Net Revenue Results
6:02am
. The Board of Directors and the Executive Leadership team remain committed to running a fulsome process that reflects the best interests of the Company
8-K
EX-99.1
k5htlgee3bnc g7ie0
21 Sep 23
Aurinia Board of Directors Appoints Dr. Robert T. Foster as New Board Director
4:06pm
8-K
EX-99.1
e50gr6ifigv3
21 Aug 23
Dr. Daniel G. Billen appointed Chair of the Board of Directors
4:11pm
PX14A6G
kebrd5 te9hp
17 May 23
Letter to shareholders
4:00pm
PX14A6G
6lg8cdzy 4v
5 May 23
Letter to shareholders
11:17am
PX14A6G
py6ly4dh3l6kdpz59g
3 May 23
Letter to shareholders
2:53pm
PX14A6G
mc60fqg
26 Apr 23
Letter to shareholders
10:20am
DEFA14A
m72j2
18 Apr 22
Additional proxy soliciting materials
7:36am
DEF 14A
mi3hlkeqogpmj f6ql
10 May 21
Definitive proxy
4:06pm
PRE 14A
y3dlpll6b 0zqk
27 Apr 21
Preliminary proxy
4:32pm
10-K
EX-10.17
wuwkwvwd0 25rsr8l78
24 Feb 21
Annual report
4:09pm
10-K
EX-10.6
jwjxjg b55d3mjr
24 Feb 21
Annual report
4:09pm